FDA Advisory Panel Recommends Approval of New Diabetes Drug (FREE)

By Amy Orciari Herman FDA advisers voted 13 to 1 on Thursday to recommend approval of the diabetes drug dapagliflozin, Reuters reports. The drug's mechanism of action — inhibition of the sodium-glucose transporter in the kidneys — leads …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news